Los Angeles Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,421
| Closed | -$390K | – | 1103 |
|
|
2024
Q4 | $390K | Buy |
15,421
+8,683
| +129% | +$219K | ﹤0.01% | 872 |
|
|
2024
Q3 | $229K | Sell |
6,738
-633
| -9% | -$21.5K | ﹤0.01% | 1088 |
|
|
2024
Q2 | $273K | Buy |
7,371
+638
| +9% | +$23.6K | ﹤0.01% | 1045 |
|
|
2024
Q1 | $283K | Buy |
+6,733
| New | +$283K | ﹤0.01% | 1022 |
|
|
2023
Q4 | – | Sell |
-16,082
| Closed | -$443K | – | 1144 |
|
|
2023
Q3 | $443K | Buy |
16,082
+56
| +0.3% | +$1.54K | ﹤0.01% | 851 |
|
|
2023
Q2 | $544K | Buy |
+16,026
| New | +$544K | ﹤0.01% | 827 |
|
|
2014
Q2 | – | Sell |
-2,435
| Closed | -$646K | – | 1215 |
|
|
2014
Q1 | $646K | Buy |
+2,435
| New | +$646K | 0.01% | 789 |
|